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Ventricular ﬁbrillation (VF) is an important cause of sudden cardiac death in patients with coronary
vasospasm. Intensive medical treatment against coronary vasospasm is most important for prevention
of VF recurrence, and the efﬁcacy of implantable cardioverter-deﬁbrillator (ICD) devices is controver-
sial. We examined 19 consecutive patients with coronary spasm who had been successfully
resuscitated from VF between 1993 and 2010, 13 of whom underwent ICD implantation. There were
no apparent differences in the results of coronary angiography and acetylcholine provocation test or in
medical therapy among them. Six patients underwent electrophysiological tests during the acetylcho-
line provocation test, and 3 of them showed ventricular arrhythmia. Three patients had recurrent VF
under treatment with single calcium channel blocker (CCB), nitrates, and/or nicorandil. Two of them
were without ICDs and were left in vegetative states, and the third was successfully resuscitated by an
appropriate ICD discharge. The results of our study suggest that dual or multiple CCB treatment is
preferable to prevent VF recurrence, and that combined treatment with ICD may be effective for some
patients with coronary vasospasm who have been successfully resuscitated from VF. However,
reasonable risk stratiﬁcation for ICD implantation in these patients needs to be established in the
future.
& 2012 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
The spread of basic life support (BLS), including use of auto-
mated external deﬁbrillators in the general public, may increase
the chance of survival from sudden cardiac death (SCD). Survivors
usually have underlying cardiac diseases, such as coronary artery
disease, cardiomyopathy, valvular heart disease, or myocardial
channel disease. Ventricular ﬁbrillation (VF) is one of the impor-
tant causes of SCD [1,2] in patients with coronary vasospasm. The
Guidelines for Risks and Prevention of Sudden Cardiac Death 2010
(Guideline 2010) [3] stated that fatal ventricular arrhythmias,
including VF, in patients with variant angina should be prevented
by intensive medical therapy against coronary vasospasm. How-
ever, there are some patients who are refractory to intensive
medical therapy and are at high risk of recurrent VF [4].
At our institution, we treated patients with coronary vasos-
pasm only by medical therapy until 2005, because we were not
permitted to perform implantation of implantable cardioverter-
deﬁbrillators (ICD) until 2004, and we started ICD therapy in
2005. Between 2005 and 2010, 13 patients who survived VF andrt Rhythm Society. Published by E
: þ81 42 464 7912.
ra, MD).had positive acetylcholine (ACh) provocation test underwent ICD
implantation in addition to medical therapy.
Although there have been reports that ICD is useful for
patients with coronary vasospasm complicated by VF [5–8],
implantation of ICD in these patients remains controversial and
is regarded as Class 2b in the Guideline 2010. In this study we
examined 19 patients with coronary vasospasm complicated with
VF and considered the effective treatment and prevention of its
recurrence.2. Methods
2.1. Study population
One hundred eighty-six patients (132 male, 54 female) with
aborted SCD were admitted to our hospital between November
1993 and February 2010. Twenty-eight of them were diagnosed
with variant angina or coronary spastic angina (CSA), and the
remaining 158 were diagnosed with other cardiac diseases. Of the
28 patients with CSA, 25 were successfully resuscitated and left
the hospital without any severe sequelae. The causes of SCD were
ventricular ﬁbrillation in 19 patients, complete atrioventricular
block in 1 patient, and unknown fatal arrhythmia in 5 patientslsevier B.V. All rights reserved.
Fig. 2. Timing, duration, and results of EPS. EPS: electrophysiological study, CAG:
coronary angiography, LCAG: left coronary angiography, ISDN: isosorbide dini-
trate, RCAG: right coronary angiography, Pt: patient, VF: ventricular ﬁbrillation,
DC: direct current, VT: ventricular tachycardia, TdP: Torsades des Pointes.
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studied the 19 patients with coronary vasospasm who were
successfully resuscitated from VF. Clinical characteristics, results
of coronary angiography (CAG), ACh provocation test, and elec-
trophysiological study (EPS), and treatment and clinical course
were compared among them.
2.2. Acetylcholine provocation test for coronary vasospasm
Seventeen patients underwent ACh provocation test. Following
control CAG, ACh was injected into the coronary artery in
incremental doses (50 and 100 mg for left coronary artery (LCA);
25 and 50 mg for right coronary artery (RCA)) under backup
pacing. A positive response was deﬁned as the development of
Z90% stenosis with or without chest pain and/or ST-segment
change on electrocardiogram (ECG). If spasm of LCA occurred,Fig. 1. Acetylcholine provocation test (Pt 15). (A) Spasm of LAD. Diffuse coronary
spasm occurred in the middle and distal segments of LAD, with mild spasm in the
distal segments of LCX. LAD: left anterior descending artery, LCX: left circumﬂex
artery. (B) Relief of spasm with ISDN. Signiﬁcant organic stenosis was not
detected. ISDN: isosorbide dinitrate.isosorbide dinitrate (ISDN) was injected to LCA and ACh provoca-
tion test for RCA was not performed unless the physician decided
to do so (Fig. 1).
2.3. Electrophysiological study for ventricular arrhythmia
Six patients underwent EPS during the ACh provocation test.
We used a programmed stimulation protocol including basic
pacing cycle length with single, double, and triple extra-stimuli
at the right ventricular apex. The timing of programmed stimula-
tion was before CAG in 1 patient who also underwent the test
after injection of acetylcholine, before injection of ACh in
1 patient, between injection of ACh and left CAG with ISDN in
2 patients, and after right CAG with ISDN in 3 patients (Fig. 2).
Basic cycle length, minimum coupling interval, and duration of
EPS are shown in Table 4.3. Results
3.1. Clinical characteristics
Clinical characteristics of all of the patients are listed in
Table 1. Patients (Pts) from 1 to 5 were admitted before we began
to perform ICD implantations. There was no past history of
syncope, and no or unknown (Pt 5) family histories of SCD. Ten
patients (53%) were smokers at onset, but all of them gave up
smoking after the event. There were more patients with hyper-
tension than with dyslipidemia (DL) or diabetes mellitus (DM).
The dominant baseline ECG rhythm was sinus rhythm in 18
patients, and no one exhibited Brugada-type ECG changes. Pt
6 had dilated phase hypertrophic cardiomyopathy (HCM) with
severely reduced left ventricular (LV) function. The other patients
demonstrated normal or mildly reduced LV function. Two
patients had histories of arrhythmia, but both of them had sinus
rhythm on admission.
3.2. Organic coronary stenoses
All of the patients underwent CAG with ISDN either emergently
or on the same day as ACh provocation test (Tables 2 and 3). Twelve
patients had normal coronary arteries, 6 had mild stenoses, and
1 had 75% stenosis of the left anterior descending artery (LAD),
which we did not regard as the cause of VF.
3.3. Diagnosis of coronary vasospasm
Chest pain and ST-segment elevation on ECG before VF detec-
tion were documented in 67% (12/18) and 38% (5/13) of the
Table 1
Clinical characteristics.
Pt no. Age/sex Onset
(month, year)
FH PH Coronary risk factors Baseline ECG ﬁndings Underlying
cardiac diseases
LV function
SCD CAD Syncope Smoking HT DL DM Rhythm Brugada-type
1 50/M November 93    þ C þ   Af   Good
2 47/F November 95    þ C þ   Sinus   EF 78
3 48/F February 00        Sinus   EF 76
4 60/M June 02    þ C þ  þ Sinus   EF 55
5 33/M May 04 NA NA  þ C    Sinus   EF 59
6 55/M September 06  NA  þ C þ   Sinus  HCM Good
7 67/M December 06  NA  þ P þ þ  Sinus  Dilated HCM EF 27
8 60/M July 07  NA  þ P þ þ  Sinus   EF 60
9 27/M November 07  NA  þ C    Sinus  Arrhythmia unknown EF 60
10 62/M May 08  NA  þ P  þ  Sinus   EF 75
11 32/M May 08  NA  þ P þ   Sinus   EF 49
12 42/F May 08    þ C    Sinus   EF 59
13 66/M November 08    þ C þ þ þ Sinus   EF 50
14 72/M November 08    þ C    Sinus  Paroxysmal Af EF 42
15 33/M July 09        Sinus   EF 62
16 34/M October 09    þ C    Sinus   Good
17 61/M November 09    þ P  þ  Sinus   AS hypokinesis
18 43/M January 10    þ P    Sinus   EF 45
19 50/M February 10    þ P þ   Sinus   Good
Pt: patient, FH: family history, SCD: sudden cardiac death, CAD: coronary artery disease, NA: not available, PH: past history, C: current, P: past, HT: hypertension,
DL: dyslipidemia, DM: diabetes mellitus, ECG: electrocardiogram, Af: atrial ﬁbrillation, HCM: hypertrophic cardiomyopathy, LV: left ventricular, EF: ejection fraction,
AS: anteroseptal.
Table 2
Organic coronary stenoses.
Pt no. CAG with intracoronary ISDN
Interval (days)a Results
1 22 Intact
2 7 Months before Intact
3 22 Intact
4 3 #7 50% #4PD 50%
5 0 Intact
6 0 Intact
7 27 Intact
8 0 #6 75%
9 4 #6 25%
10 0 Intact
11 0 Intact
12 10 Intact
13 0 #7 50% #2-3 50%
14 0 #7 50%
15 0 Intact
16 15 Intact
17 0 #6 50%
18 0 Intact
19 0 #6 50%
Pt: patient, CAG: coronary angiogram, ISDN: isosorbide
dinitrate, RCA: right coronary artery.
a Interval between the days of onset and CAG.
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pasm by prior chest pain and transient ST-segment elevation on
ECG, Pt 2 was previously diagnosed in another hospital 7 months
before, and the remaining 17 patients were diagnosed by positive
ACh provocation test.
ACh provocation test was performed 3 to 45 (mean7SD;
15.6710.8) days after the onset of VF, and 71% (12/17) of the
patients underwent it after washout of anti-spastic medication.
Spasm of the LAD was documented in all 17 patients, 3 of
whom (18%) complained of chest pain. At least 6 (35%) exhibited
ST-segment change on 12-lead ECG; however, VF was not docu-
mented in any patients. In 15 patients, we injected ISDN to the
LCA after the induction of spasm and did not perform the
induction of RCA spasm. In Pt 14, spasm of RCA occurred duringcontrol CAG. Spasm of RCA was documented in 1 of the remaining
2 patients (Table 3).
Pilsicainide challenge test was performed in Pts 9 and 15, and
was negative in both.
3.4. Electrophysiological study
Results of the EPS during ACh provocation test are shown in
Fig. 2 and Table 4. All of these 6 patients underwent induction of
only LCA spasm.
VF was induced and successfully terminated by direct current
shock in Pt 19, who was under medical treatment with diltiazem
R, nicorandil, and isosorbide mononitrate (ISMN). He underwent
ACh provocation test after VF induction, and benidipine was
added after the positive test.
Two patients who underwent EPS during LCA spasm (Pts 10
and 18) did not exhibit ventricular arrhythmia. Pt 18 also under-
went the test before CAG and demonstrated only 1 echo. Two of
3 patients who underwent EPS after relief of LCA spasm devel-
oped non-sustained ventricular tachycardia and Torsades des
Pointes, respectively. The other (Pt 9) showed negative responses
to both EPS and Pilsicainide challenge test.
3.5. Medical treatment
Medication of all the patients is shown in Table 5. Drugs were
selected at the discretion of each physician.
Intravenous Nitroglycerin had been used for Pts 13 and 17
until the ACh provocation test. Calcium channel blockers (CCBs)
were administered for all of the patients, of which Diltiazem R
was the most common (79%; 15/19). Thirteen patients received a
single CCB, and 6 received dual CCBs. Nicorandil and ISMN were
administered to 53% (10/19) and 68% (13/19) of the patients,
respectively. Eleven patients (58%) were started on additional
drugs for prevention of coronary vasospasm after the positive
ACh test.
Statins were administered for patients with DL, except for Pt
15, with the aim of anti-spastic effect. Amiodarone was used with
the aim of controlling VF, but there was no standard of admin-
istration among the physicians.
Table 3
Diagnosis of coronary spasm.
Pt no. Signs and symptoms before VF onset ACh provocation test
Chest pain ST-segment
elevation
Interval
(days)a
Medicationb ACh
(mg) to LCA
ACh (mg)
to RCA
Site of
spasm
During spasm EPS on the
same day
Chest pain ST-T change
1 þ þ
2 þ þ
3 þ  22 C 50 50 LCA, RCA  k 
4 þ  3 D 50 0 LCA  k (V2-6) 
5 þ NA 15 D 100 0 LCA  m (II, III, aVF) 
k (V5-6, aVL) 
6   17 D 100 0 LAD  NA þ
7 þ  27 D 100 0 LAD   þ
8   17 D 100 0 LAD NA NA 
9 þ  4 D 100 0 Distal LAD  k (V3-5) þ
10 þ þ 7 C 100 0 LCA  m (V2-4) þ
11   15 C 100 0 LCA   
12 þ NA 10 D 50 0 LCA þ NA 
13 þ þ 4 D 100 0 LCA NA NA 
14  þ 30 C 50 0 RCA, LCA   
15  NA 13 D 100 50 LAD þ  
16 NA NA 15 D 100 0 Distal LAD   
17 þ NA 7 D 50 0 Proximal LAD   
18 þ NA 45 D 50 0 LCA þ m (V1-5) þ
19   15 C 50 0 LCA NA  þ
Pt: patient, VF: ventricular ﬁbrillation, ACh: acetylcholine, LCA: left coronary artery, RCA: right coronary artery, LAD: left anterior descending artery, NA: not available,
EPS: electrophysiological study.
a Interval between the days of onset and ACh provocation test.
b Whether anti-spastic drugs were continued (C) or discontinued (D) during the test.
Table 4
Details of EPS.
Pt no. BCL (ms) Minimum coupling interval (ms) Duration (min) Results and CL (ms)
Single Double Triple
6 400 220 230–220 – 3 NSVT of 16 beats, 200 ms
7 600 280 260–210 280–220–210 3 TdP of 13 beats, 230 ms
9 600 340 340–270 320–280–230 3 No echo
400 – – 320–280–250 3 1 Echo
10 600 – – 280–230–180 1 1 Echo
18-1 500 240 240–180 240–180–180 3.5 1 Echo
18-2 450 – – 240–180–160 1 2 Echoes
19 500 – – 260–200–180 2 VF terminated by DC shock, 160 ms
Pt: patient, BCL: basic cycle length, CL: cycle length, NSVT: non-sustained ventricular tachycardia, TdP: Torsades des Pointes, VF: ventricular
ﬁbrillation, DC: direct current.
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We offered ICD implantation to 14 patients between 2005 and
2010, and 13 underwent the procedure without any severe
complications (Table 5). Pt 12 refused ICD implantation because
of her belief that she could not accept any artiﬁcial device
implanted in the body.
3.7. Clinical course
All of the patients who were smokers stopped smoking after
admission. All of them continued to take their medicine and had
regular medical examinations. Sixteen patients were free from chest
symptoms and doing well as of August 2010. One had died of cancer.
VF recurred in 3 patients (16%), Pts 3, 5, and 15, with intervals
of 85 day, 21 day, and 6 months between the 2 attacks of VF,
respectively. None of them had organic coronary stenosis and all
had positive ACh provocation tests and had been taking Diltiazem
R with Nicorandil and/or nitrates at the time of VF recurrence(Table 5). Preceding chest pain was documented before both the
ﬁrst and second attacks in Pt 3, only before the ﬁrst attack in Pt 5,
and was not documented in Pt 15. Pts 3 and 5 were resuscitated
from the second VF by usual cardiopulmonary resuscitation, but
both remained in vegetative states, and 1 died from tracheoinno-
minate artery ﬁstula. Pt 15 was successfully resuscitated from the
second VF by an appropriate discharge of the ICD (Fig. 3), and
recurrence of VF has not been documented for more than 1 year
since his physician added benidipine (4 mg) and nitroglycerin
tape (25 mg) to his medications.4. Discussion
There were not apparent differences of clinical characteristics
among the 3 patients with VF recurrence and the remaining
patients. Five patients had reduced LV function, which might have
been caused by post-resuscitative LV dysfunction, except in Pt 7,
who had dilated phase HCM.
Table 5
Treatment and clinical course.
Pt
no.
Calcium channel blockers (mg) Nicorandil
(mg)
ISMN
(mg)
ISDN
(mg)
Amiodarone
(mg)
Statin ICD implantation
(date)
Recurrence of VF
(interval)
ICD shock
delivery
Diltiazem
R
Nifedipine
CR
Amlodipine Benidipine
1 20 2.5   
2 200   
3 200 40
Added
  þ (85 day)
4 200
Added
5 40
Added
  
5 200 20 Added 40   þ (21 day)
6 200 40  þ (October 06)  
7 200 10 40 100  þ (January 07)  
8 200 20 40
Added
100 þ þ (August 07)  
9 200
Added
20 40 100  þ (November 07)  
10 100 20 20
Added
þ þ (May 08)  
11 20 Added (5)a 100  þ (June 08)  
12 20 Added 8 Added 40    
13 200 20 Added 20 Added 40 þ þ (November 08)  
14 200 8 Added 20 40 40
Added
 þ (December 08)  
15 200 40 (100)* þ þ (July 09) þ (6 months) þ
Appropriate
16 200 15 40 (100)*  þ (November 09)  
17 (200)* 16 Added 20 Added 100 þ þ (November 09)  
18 200 40  þ (March 10)  
19 200 8 Added 15 80  þ (March 10)  
Pt: patient, ISMN: isosorbide mononitrate, ISDN: isosorbide dinitrate, ICD: implantable cardioverter-deﬁbrillator, VF: ventricular ﬁbrillation.
‘‘Added’’ indicates additional drugs after positive acetylcholine provocation test.
a Numbers in parentheses indicate drugs ceased after acetylcholine provocation test.
Fig. 3. ECG recorded by ICD. VF was detected and successfully terminated by ICD, followed by backup pacing rhythm. ECG before the VF detection was not recorded
unfortunately. ECG: electrocardiogram, ICD: implantable cardioverter-deﬁbrillator, VF: ventricular ﬁbrillation.
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only by the results of coronary angiography, which did not agree
with the Guidelines for Diagnosis and Treatment of Patients with
Coronary Spastic Angina (JCS 2008) [9], because we do not believethat coronary vasospasm always leads to chest pain and/or ST-
segment changes [10]. Although the ACh provocation test is
useful for diagnosis of multiple coronary vasospasm [9], we
performed the test only in the LCA in most of the patients because
A. Ishihara et al. / Journal of Arrhythmia 28 (2012) 105–110110the avoidance of VF recurrence caused by multiple coronary
vasospasms during the test, in accordance with the fact that site
and degree of coronary spasm can migrate [10], was more
important than diagnosis of multiple spasms.
We concluded that coronary vasospasm had contributed to VF
occurrence in these 19 patients by absence of Brugada-type ECG
and absence of signiﬁcant coronary stenosis. Whether to perform
EPS and/or pilsicainide challenge test depended on each physi-
cian’s decision.
Measures for prevention of coronary vasospasm include smok-
ing cessation, stent implantation for focal vasospasm, and medical
treatment. In this study, all of the patients with smoking habits
stopped smoking after the admission, and no one underwent
stent implantation. Which drugs to prescribe and whether or not
to take a washout period before ACh provocation test were at the
discretion of each physician.
We found it difﬁcult to evaluate the efﬁcacy of EPS and medical
treatment because of this lack of consistency, so it remains most
important to establish standards for both diagnostic procedures and
medical therapy for coronary vasospasm complicated with VF.
Patients with coronary vasospasm and VF have heterogeneous
clinical manifestations, such as ST-segment elevation or depres-
sion, variant angina [4,5] or silent myocardial ischemia [1,11], and
negative results of EPS [2] or positive results even without
coronary spasm [12].
In this study, relatively few patients presented with chest pain
or documentation of ST-segment change, no one showed VF
secondary to vasospasm induced by ACh injection, and VF was
induced by EPS during ACh provocation test only in 1 patient, who
was under treatment with CCB, Nicorandil, and nitrate. Three
patients with recurrent VF had been taking a single CCB, which
suggested that dual or even triple CCBs were necessary to prevent
VF recurrence, but 10 other patients taking single a CCB have not
had VF recurrence. These facts suggested that there is no measure
to predict VF recurrence and even intensive medical therapy is
not always effective to prevent it.
Preparations for VF recurrence include education in BLS,
especially for family members and others close to the patients,
and ICD implantation. Although there are reports of limitations of
ICDs, such as inappropriate discharge [13] and complication of VF
storm and pulseless electrical activity [5,14], there are also
reports of successful combination therapy with medical treat-
ment, stent implantation, and/or ICD implantation [5–8] The fact
that 1 of 13 patients with ICD implantation was successfully
converted from VF recurrence encourages us to prepare for the
worst, i.e., recurrence of VF under intensive medical therapy, by
taking all possible measures, including ICD implantation.We concluded that (1) single CCB treatment is insufﬁcient in
patients who suffered aborted SCD associated with coronary
vasospasm, (2) dual or multiple CCB treatment is desired in such
patients, and (3) combined treatment with ICD may be required
in such patients but reasonable risk stratiﬁcation needs to be
established in the future.Conﬂict of interest
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